Thomas Bryrup
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Borrelia or Bell's? Development of BoB: a clinical decision support tool to differentiate Lyme neuroborreliosis facial palsy from Bell's palsy.
Journal: Ticks and tick-borne diseases
Published: June 01, 2026
Evaluating the Diagnostic Accuracy of Point-of-Care CXCL13 Measurements for Lyme Neuroborreliosis.
Journal: Diagnostics (Basel, Switzerland)
Published: March 06, 2026
A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO).
Journal: BMC gastroenterology
Published: January 19, 2026
Anti-NMDAR antibodies are not prevalent in Lyme neuroborreliosis: a retrospective cohort study.
Journal: BMC neurology
Published: August 25, 2025
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 28, 2025
Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: May 12, 2025
Glycemic Variability and Diabetic Events in Hospitalized Patients With COVID-19 Treated With Dexamethasone: An Observational Cohort Study.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: April 28, 2025
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort.
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 25, 2025
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: April 23, 2025
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 03, 2025
Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trial.
Journal: Cell reports. Medicine
Published: February 13, 2025
Tick-borne encephalitis in adults in Denmark: a nationwide prospective cohort study from 2015 to 2023.
Journal: Journal of neurology
Published: December 22, 2024
Last Updated: 09/26/2026